REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Jg Apteki Sp. z o.o. (Poland)

Main Activities: Department Stores
Secondary Activities: Pharmaceutical Preparation Manufacturing | All Other Specialty Food Stores | Pharmacies and Drug Stores | Cosmetics, Beauty Supplies, and Perfume Stores | Lessors of Real Estate | Other Commercial and Industrial Machinery and Equipment Rental and Leasing | Advertising, Public Relations, and Related Services | All Other Miscellaneous Schools and Instruction
Full name: Jg Apteki Sp. z o.o. Profile Updated: May 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Jg Apteki Sp. z o.o. is an enterprise in Poland, with the main office in Pogorzela. The company operates in the Department Stores sector. It was established on April 28, 2017. The company’s latest financial report indicates a net sales revenue increase of 2.4% in 2023. A growth of 38.7% was recorded in its total assets. The net profit margin of Jg Apteki Sp. z o.o. decreased by 1.16% in 2023.

Headquarters
Ul. Elizy Orzeszkowej 9
Pogorzela; Wielkopolskie; Postal Code: 63-860

Contact Details: Purchase the Jg Apteki Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Jg Apteki Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Jg Apteki Sp. z o.o. report to view the information.
Incorporation Date:
April 28, 2017
Key Executives
Purchase this report to view the information.
President
Company Performance
Financial values in the chart are available after Jg Apteki Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
2.4%▲
Total operating revenue
2.53%▲
Operating profit (EBIT)
-8.96%▼
EBITDA
-7.15%▼
Net Profit (Loss) for the Period
-10.4%▼
Total assets
38.7%▲
Total equity
39.93%▲
Operating Profit Margin (ROS)
-1.03%▼
Net Profit Margin
-1.16%▼
Return on Equity (ROE)
-20.63%▼
Quick Ratio
0.51%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo